Literature DB >> 3263692

Cellular regulation of anti-nRNP antibody synthesis is different from that of anti-DNA antibody synthesis in patients with systemic lupus erythematosus.

O Hosono1, T Takeuchi, J Koide, M Takano, T Abe.   

Abstract

The cellular regulation of anti-nuclear ribonucleoprotein (nRNP) antibody synthesis in patients with systemic lupus erythematosus (SLE) was examined and compared with that of anti-double-stranded DNA (dsDNA) antibodies. In vitro antibody production by lymphocytes from SLE patients with antibodies to either dsDNA or nRNP alone was measured using dsDNA-specific and nRNP-specific solid-phase radioimmunoassays (RIA). Lymphocytes of SLE patients with only anti-dsDNA antibodies and normal individuals failed to synthesize anti-nRNP antibody with or without nRNP stimulation. In contrast, lymphocytes from SLE patients with anti-nRNP antibody alone in their sera synthesized in vitro a large amount of anti-nRNP antibody with or without nRNP stimulation. Experiments with reconstituted autologous lymphocytes indicated that B cells and T cells were required for anti-nRNP antibody synthesis. As expected, helper function for antibody synthesis by autologous B cells resided in the T4-cell population and suppressor function in the T8-cell population. T8 cells from SLE patients with anti-nRNP antibody alone suppressed anti-nRNP antibody synthesis by autologous B cells irrespective of clinical activity. This is in contrast to anti-dsDNA antibody production, which was not suppressed by autologous T8 cells. These results indicate that the cellular regulation of anti-nRNP antibody synthesis in SLE is different from that of anti-dsDNA antibody synthesis. Increased anti-nRNP antibody synthesis may be due to increased T4-helper cell function rather than defective T8-suppressor function.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263692     DOI: 10.1007/bf00270457

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  23 in total

1.  A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

2.  In vitro production of autoantibodies to U1 ribonucleoproteins by peripheral blood mononuclear cells from patients with connective tissue diseases.

Authors:  Y Ohosone; M Akizuki; M Hirakata; M Satoh; H Yamagata; M Homma
Journal:  Arthritis Rheum       Date:  1986-11

3.  Molecular relationships between two nuclear antigens, ribonucleoprotein and Sm: purification of active antigens and their biochemical characterization.

Authors:  M Takano; S S Golden; G C Sharp; P F Agris
Journal:  Biochemistry       Date:  1981-10-13       Impact factor: 3.162

4.  Suppressor cell loss and dysfunction in mixed connective tissue disease.

Authors:  D Alarcón-Segovia; A Ruíz-Arguelles
Journal:  Arthritis Rheum       Date:  1980-03

5.  Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA).

Authors:  G C Sharp; W S Irvin; E M Tan; R G Gould; H R Holman
Journal:  Am J Med       Date:  1972-02       Impact factor: 4.965

6.  Immunologic regulation of spontaneous antibodies to DNA and RNA I. Significance of IgM and IgG antibodies in SLE patients and asymptomatic relatives.

Authors:  N Talal; R J Pillarisetty; R J DeHoratius; R P Messner
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

7.  A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease.

Authors:  W D Sullivan; D J Hurst; C E Harmon; J H Esther; G A Agia; J D Maltby; S B Lillard; C N Held; J F Wolfe; E V Sunderrajan
Journal:  Medicine (Baltimore)       Date:  1984-03       Impact factor: 1.889

8.  Cellular mechanism of DNA-specific antibody synthesis by lymphocytes from systemic lupus erythematosus patients.

Authors:  T Takeuchi; T Abe; J Koide; O Hosono; C Morimoto; M Homma
Journal:  Arthritis Rheum       Date:  1984-07

9.  Studies of immune functions of patients with systemic lupus erythematosus. I. Dysfunction of suppressor T-cell activity related to impaired generation of, rather than response to, suppressor cells.

Authors:  T Sakane; A D Steinberg; I Green
Journal:  Arthritis Rheum       Date:  1978 Jul-Aug

10.  Spontaneous production of antibodies to deoxyribonucleic acids in patients with systemic lupus erythematosus.

Authors:  T Takeuchi
Journal:  Clin Immunol Immunopathol       Date:  1985-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.